Skip to main content
. 2021 Jul 22;12(8):726. doi: 10.1038/s41419-021-04015-w

Fig. 1. Immunostaining of MAP1LC3B in PCa and normal prostate tissues.

Fig. 1

A Low expression of MAP1LC3B detected in normal prostate tissues. BD High expression of MAP1LC3B detected in prostate cancer tissues. E, F Statistical analysis revealed MAP1LC3B was lowly expressed in non-cancerous prostate tissues, whereas highly expressed in PCa tissues, and correlated positively with Gleason score.